For: | Parida JR, Misra DP, Wakhlu A, Agarwal V. Is non-biological treatment of rheumatoid arthritis as good as biologics? World J Orthop 2015; 6(2): 278-283 [PMID: 25793168 DOI: 10.5312/wjo.v6.i2.278] |
---|---|
URL: | https://www.wjgnet.com/2218-5836/full/v6/i2/278.htm |
Number | Citing Articles |
1 |
Edyta Brzustewicz, Ewa Bryl. The role of cytokines in the pathogenesis of rheumatoid arthritis – Practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine 2015; 76(2): 527 doi: 10.1016/j.cyto.2015.08.260
|
2 |
Lukasz S. Wylezinski, Jamieson D. Gray, Julia B. Polk, Andrew J. Harmata, Charles F. Spurlock. Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes. Journal of Clinical Medicine 2019; 8(4): 493 doi: 10.3390/jcm8040493
|
3 |
Bonnie Williams, Eleni Tsangari, Romany Stansborough, Victor Marino, Melissa Cantley, Anak Dharmapatni, Rachel Gibson, Egon Perilli, Tania Crotti. Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis. Inflammopharmacology 2017; 25(1): 55 doi: 10.1007/s10787-016-0306-z
|
4 |
Durga Prasanna Misra, Vikas Agarwal, Aman Sharma, Anupam Wakhlu, Vir Singh Negi. 2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?. Annals of the Rheumatic Diseases 2017; 76(11): e47 doi: 10.1136/annrheumdis-2017-211446
|
5 |
DurgaPrasanna Misra, Vikas Agarwal. Comment on: A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice. Indian Journal of Rheumatology 2018; 13(1): 75 doi: 10.4103/injr.injr_152_17
|
6 |
Rupa Banerjee, Partha Pal, Amulya Penmetsa, Pradip Kathi, Ganesh Girish, Idan Goren, D. Nageshwar Reddy. Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis. Journal of Clinical Gastroenterology 2021; 55(8): 702 doi: 10.1097/MCG.0000000000001416
|
7 |
Qing-Chun Huang, Mao-Jie Wang, Xiu-Min Chen, Wan-Lin Yu, Yong-Liang Chu, Xiao-Hong He, Run-Yue Huang. Can active components of licorice, glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis?. Oncotarget 2016; 7(2): 1193 doi: 10.18632/oncotarget.6200
|
8 |
Ruolin Liu, Qianyi Wan, Rui Zhao, Haitao Xiao, Ying Cen, Xuewen Xu. Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02325-9
|
9 |
Sara Momtazmanesh, Ali Nowroozi, Nima Rezaei. Artificial Intelligence in Rheumatoid Arthritis: Current Status and Future Perspectives: A State-of-the-Art Review. Rheumatology and Therapy 2022; 9(5): 1249 doi: 10.1007/s40744-022-00475-4
|
10 |
Durga Prasanna Misra, Vikas Agarwal. The perennial search for alternatives to corticosteroids in rheumatology: is there light at the end of the tunnel?. Clinical Rheumatology 2020; 39(10): 2845 doi: 10.1007/s10067-020-05357-0
|
11 |
Bonnie Williams, Anak Dharmapatni, Tania Crotti. Intracellular apoptotic pathways: a potential target for reducing joint damage in rheumatoid arthritis. Inflammation Research 2018; 67(3): 219 doi: 10.1007/s00011-017-1116-5
|
12 |
Neslihan Sevimli, Remzi Karadag, Ercan Madenci, Huseyin Bayramlar, Pinar Arslan, Ayse Ocal, Yasar Dag. Ocular surface findings in patients with rheumatoid arthritis under methotrexate or biological agent therapy. Cutaneous and Ocular Toxicology 2017; 36(1): 48 doi: 10.3109/15569527.2016.1144193
|